Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Sex Linked Disorders

Sex Linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The DBD-α4 helix of EWSR1::FLI1 is required for GGAA microsatellite binding that underlies genome regulation in Ewing sarcoma.

eLife·2026

Same author

Development and implementation of an LC-MS-based multi-attribute method for adeno-associated virus.

Molecular therapy. Methods & clinical development·2025

Same author

DBD-α4 helix of EWSR1::FLI1 is required for GGAA microsatellite binding that underlies genome regulation in Ewing sarcoma.

bioRxiv : the preprint server for biology·2024

Same author

Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023

Same author

The ETS transcription factor ETV6 constrains the transcriptional activity of EWS-FLI to promote Ewing sarcoma.

Nature cell biology·2023

Same author

Adverse prognostic impact of the loss of STAG2 protein expression in patients with newly diagnosed localised Ewing sarcoma: A report from the Children's Oncology Group.

British journal of cancer·2022

Search research articles

Related Experiment Video

Updated: May 29, 2026

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

Promiscuous partnerships in Ewing's sarcoma.

Savita Sankar¹, Stephen L Lessnick

¹Department of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, UT, USA.

Cancer Genetics

|August 30, 2011

Summary

Ewing's sarcoma is driven by TET/ETS gene fusions, like EWS/FLI. This review explores these and similar fusions in Ewing's-like tumors, crucial for understanding this aggressive cancer.

Area of Science:

Oncology
Molecular Genetics
Cancer Biology

Background:

Ewing's sarcoma is a rare, aggressive bone and soft tissue cancer affecting children and young adults.
It is molecularly defined by specific gene fusions, primarily the EWS/FLI oncogenic transcription factor.
These fusions are critical for tumor development and serve as diagnostic markers.

Purpose of the Study:

To review the spectrum of fusion oncogenes in Ewing's sarcoma and Ewing's-like tumors.
To highlight the role of TET/ETS fusions in Ewing's sarcoma pathogenesis.
To identify key questions for future research into these malignancies.

Main Methods:

Literature review of studies on Ewing's sarcoma and related tumors.
Analysis of molecular genetic data, focusing on gene fusions.

More Related Videos

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

Related Experiment Videos

Last Updated: May 29, 2026

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

Synthesis of current understanding of fusion oncogene mechanisms.

Main Results:

Ewing's sarcoma is characterized by TET/ETS fusions, with EWS/FLI being the most common.
Variant TET/ETS fusions are also implicated in Ewing's sarcoma.
Rare "Ewing's-like tumors" exhibit EWS fusions with non-ETS proteins.

Conclusions:

TET/ETS fusions are central to Ewing's sarcoma development.
Further research is needed to clarify the role of non-ETS fusions in Ewing's-like tumors.
Understanding fusion oncogene mechanisms is key to advancing Ewing's sarcoma treatment.